make me feel a little more comfortable about the Q2 earnings release
Please mark, note my footnote also.
I will remain on the sideline till 10-Q (more precisely till / after10-Q by CROX on Aug 4.). Meanwhile I think the "yearly" decline was built in after the 10-Q1, I will not be surprised by a 10-20+% drop after the current report (due to Q2 2022 vs Q2 2021 comparison) ... the market won't see the forest due to the tree. Independently from drop / no drop it will be a good entry point after the release: - we will no Q2 (one overhang will be removed) and - hopefully - we will get some (but not revenue) guidline during the CC - (at least) France and Germany will issue the decision - more likely - in Q3 - China will approve Vascepa and it could come any day - Other announcement(s) - e.g. regarding non key EU countries / region like CEE - could come also in Q3